Japan

© GettyImages/Bet_Noire

Japan backs Takeda stem cell therapy targeting Crohn’s disease

By Jane Byrne

Takeda has received approval from Japan’s ministry of health to manufacture and market its stem cell therapy, Alofisel, for the treatment of complex perianal fistulas in patients with non-active or mildly active luminal Crohn’s disease (CD).